Raphael J Morscher, Sarah Catharina Grünert, Céline Bürer, Patricie Burda, Terttu Suormala, Brian Fowler, Matthias R Baumgartner
Division of Metabolism and Children's Research Center, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland. raphael.morscher@pmu.ac.at
Molecular genetics and metabolism 2012 AprIsolated 3-Methylcrotonyl-CoA carboxylase deficiency (MCC deficiency) is an organic aciduria presenting with a highly variable phenotype and has been part of newborn screening programs in various countries, in particular in the US. Here we present enzymatic and genetic characterisation of 22 individuals with increased 3-hydroxyisovalerylcarnitine and/or 3-methylcrotonylglycine suggesting MCC deficiency, but only partially reduced 3-methylcrotonyl-CoA carboxylase activity. Among these, 21 carried a single mutant allele in either MCCC1 (n=20) or MCCC2 (n=1). Our results suggest that heterozygosity for such a single deleterious mutation may lead to misdiagnosis of MCC deficiency. Copyright © 2011 Elsevier Inc. All rights reserved.
Raphael J Morscher, Sarah Catharina Grünert, Céline Bürer, Patricie Burda, Terttu Suormala, Brian Fowler, Matthias R Baumgartner. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency. Molecular genetics and metabolism. 2012 Apr;105(4):602-6
PMID: 22264772
View Full Text